July 18, 2019 / 5:18 AM / 5 months ago

BRIEF-Cassiopea Generates No Revenue In H1 2019

July 18 (Reuters) - CASSIOPEA SPA:

* NO REVENUES WERE GENERATED IN H1 2019

* VERY POSITIVE RESULTS FROM PHASE III OPEN LABEL SAFETY STUDY EVALUATING WINLEVI®/CLASCOTERONE 1 % CREAM FOR ACNE FOR TREATMENT UP TO ONE YEAR

* VERY POSITIVE PHASE II TWELVE MONTHS DOSE RANGING STUDY RESULTS FOR BREEZULA®/CLASCOTERONE SOLUTION IN TREATING ANDROGENETIC ALOPECIA

* NDA FOR WINLEVI®/CLASCOTERONE TO BE FILED SHORTLY

* ALL COSTS WITHIN APPROVED/FORESEEN BUDGET Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below